×







We sell 100% Genuine & New Books only!

Pancreatic Disease Basic Science and Clinical Management 1st Editon 2012 Softbound at Meripustak

Pancreatic Disease Basic Science and Clinical Management 1st Editon 2012 Softbound by Clement W. Imrie, Colin D. Johnson, Springer

Books from same Author: Clement W. Imrie, Colin D. Johnson

Books from same Publisher: Springer

Related Category: Author List / Publisher List


  • Price: ₹ 13807.00/- [ 15.00% off ]

    Seller Price: ₹ 11736.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s)Clement W. Imrie, Colin D. Johnson
    PublisherSpringer
    Edition1st Edition
    ISBN9781447134916
    Pages490
    BindingSoftbound
    LanguageEnglish
    Publish YearAugust 2012

    Description

    Springer Pancreatic Disease Basic Science and Clinical Management 1st Editon 2012 Softbound by Clement W. Imrie, Colin D. Johnson

    Pancreatic Disease: Basic Science and Clinical Management summarises the state of the art in basic science and clinical management of pancreatic disease. This book provides a clear and up-to-date review of the advancing areas in clinical pancreatology and clinical research related to the pancreas. Written by leading experts in the field, this comprehensive review directs the interested reader towards important and current published source material. Covering all aspects of pancreatic disease, contributions are included from pancreatic surgeons and medical pancreatologists on pancreatic cancer, acute pancreatitis and chronic pancreatitis. Special features include a systematic review of the evidence for the use of gemcitabine in pancreatic cancer prepared for the National Institute of Clinical Excellence (NICE), the UK body charged with evaluating new drug treatment. Gemcitabine has FDA approval. There are several contributions dealing with the management of pancreatic neuroendocrine tumours. This book will be useful to gastroenterologists, internists and surgeons, and specialist clinicians with an interest in pancreatic disease. Trainees in medical and surgical pancreatology will find it a companion to supplement standard textbooks. 1 Epidemiology of Pancreatic Neuroendocrine Tumours.- 2 Quality of Life Issues Identified by Healthcare Workers and Patients with Metastatic Carcinoid/Neuroendocrine Tumours.- 3 Diagnosis and Localisation of Insulinoma.- 4 GI Hormone Producing Tumours: Syndromes and Treatment Options.- 5 Progress by Collaboration: ESPAC Studies.- 6 Gemcitabine: a Systematic Review.- 7 Farnesyl Protein Transferase Inhibitors in Pancreatic Cancer.- 8 Novel Alternatives to Chemotherapy in Advanced Disease: Gastrin Antibodies.- 9 Novel Alternatives to Chemotherapy in Advanced Disease: Gene Transfer.- 10 Suicide Gene Therapy for Pancreatic Cancer.- 11 Pancreatic Cystic Lesions and Neoplasms.- 12 Pancreatic Involvement in Von Hippel-Lindau Disease.- 13 Intraductal Papillary Mucinous Tumours of the Pancreas.- 14 Endoscopic Ultrasound in the Diagnosis of Chronic Pancreatitis and Pancreatic Cancer.- 15 Natural Course of Chronic Pancreatitis.- 16 Autoimmune Pancreatitis.- 17 What’s New in Pancreatic Stellate Cell Biology?.- 18 Pancreatic Stellate Cells and their Role in Fibrogenesis.- 19 Factors Influencing Pancreatic Stellate Cell Phenotype and Cell Turnover.- 20 Acinar-Islet Cell Interactions: Diabetes Mellitus in Chronic Pancreatitis.- 21 Acinar-Islet Interactions: Pancreatic Exocrine Insufficiency in Diabetes Mellitus.- 22 Genetic Basis of Hereditary and Sporadic Pancreatitis.- 23 Cytokines in Chronic Pancreatitis.- 24 Cytokine Gene Polymorphisms in Acute Pancreatitis.- 25 Genetic Polymorphism, the Immune Response and Chronic Pancreatitis.- 26 Xenobiotic Metabolising Enzymes in Pancreatitis.- 27 Trypsin Activation and Inhibition in Pancreatitis.- 28 Selecting Patients for Trials and Treatment: Apache-II?.- 29 Selecting Severe Cases of Acute Pancreatitis for Trials and for Treatment: Enzymes and Activation Peptides.- 30 Selecting Severe Cases of Acute Pancreatitis on the Basis of Organ Failure.- 31 Individual Features Related to Severity in Acute Pancreatitis.- 32 Sterile Necrosis in Acute Necrotizing Pancreatitis: Current Concepts and Management Strategies.- 33 Management of Infected Pancreatic Necrosis.- 34 Antibiotics in Acute Pancreatitis.- 35 Enteral Nutrition in Acute Pancreatitis: Mucosal Barrier.- 36 Early Enteral Nutrition and Markers of the Inflammatory Response in Severe Acute Pancreatitis.- 37 Enteral Nutrition in Acute Pancreatitis: Clinical Outcome.- 38 Measurement of Symptoms and Quality of Life in Pancreatic Disease.- 39 Mechanism of Nociception in Chronic Pancreatitis.- 40 Bilateral Thoracoscopic Splanchnicectomy in the Management of Pain in Patients with Chronic Pancreatitis.- 41 Nerve Pathways for Pain.- 42 Pain Management in Chronic Pancreatitis.- 43 Pancreatic Decompression in Chronic Pancreatitis.



    Book Successfully Added To Your Cart